These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 10561344)

  • 1. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects.
    Stuschke M; Eberhardt W; Pöttgen C; Stamatis G; Wilke H; Stüben G; Stöblen F; Wilhelm HH; Menker H; Teschler H; Müller RD; Budach V; Seeber S; Sack H
    J Clin Oncol; 1999 Sep; 17(9):2700-9. PubMed ID: 10561344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial.
    Pöttgen C; Eberhardt W; Grannass A; Korfee S; Stüben G; Teschler H; Stamatis G; Wagner H; Passlick B; Petersen V; Budach V; Wilhelm H; Wanke I; Hirche H; Wilke HJ; Stuschke M
    J Clin Oncol; 2007 Nov; 25(31):4987-92. PubMed ID: 17971598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens.
    Topkan E; Parlak C; Kotek A; Yuksel O; Cengiz M; Ozsahin M; Pehlivan B
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1264-71. PubMed ID: 22172902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
    Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A;
    Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain Metastases.
    Park HS; Decker RH; Wilson LD; Yu JB
    Clin Lung Cancer; 2015 Jul; 16(4):292-7. PubMed ID: 25499149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metastases in N2-positive non-small-cell lung cancer: implications for prophylactic cranial irradiation.
    Bansal M; Boyle T; Ehsan A; Mott FE
    Clin Lung Cancer; 2008 Jul; 9(4):227-9. PubMed ID: 18650171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of prophylactic cranial irradiation in regionally advanced non-small cell lung cancer. A Southwest Oncology Group Study.
    Rusch VW; Griffin BR; Livingston RB
    J Thorac Cardiovasc Surg; 1989 Oct; 98(4):535-9. PubMed ID: 2552227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.
    Li N; Zeng ZF; Wang SY; Ou W; Ye X; Li J; He XH; Zhang BB; Yang H; Sun HB; Fang Q; Wang BX
    Ann Oncol; 2015 Mar; 26(3):504-9. PubMed ID: 25515658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Present role of prophylactic cranial irradiation].
    Le Péchoux C; Al Mohkles H; Dhermain F
    Bull Cancer; 2013 Jan; 100(1):35-43. PubMed ID: 23306141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic cranial irradiation for patients with lung cancer.
    Pugh TJ; Gaspar LE
    Clin Lung Cancer; 2007 May; 8(6):365-8. PubMed ID: 17562236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation.
    Komaki R; Meyers CA; Shin DM; Garden AS; Byrne K; Nickens JA; Cox JD
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):179-82. PubMed ID: 7642416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?
    Carolan H; Sun AY; Bezjak A; Yi QL; Payne D; Kane G; Waldron J; Leighl N; Feld R; Burkes R; Keshavjee S; Shepherd F
    Lung Cancer; 2005 Jul; 49(1):109-15. PubMed ID: 15949596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic cranial irradiation in locally advanced non-small cell lung cancer: outcome of recursive partitioning analysis group 1 patients.
    Yavuz AA; Topkan E; Onal C; Yavuz MN
    J Exp Clin Cancer Res; 2008 Dec; 27(1):80. PubMed ID: 19055787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).
    Eberhardt WE; Pöttgen C; Gauler TC; Friedel G; Veit S; Heinrich V; Welter S; Budach W; Spengler W; Kimmich M; Fischer B; Schmidberger H; De Ruysscher D; Belka C; Cordes S; Hepp R; Lütke-Brintrup D; Lehmann N; Schuler M; Jöckel KH; Stamatis G; Stuschke M
    J Clin Oncol; 2015 Dec; 33(35):4194-201. PubMed ID: 26527789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases.
    Shaw EG; Su JQ; Eagan RT; Jett JR; Maksymiuk AW; Deigert FA
    J Clin Oncol; 1994 Nov; 12(11):2327-32. PubMed ID: 7964948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of prophylactic cranial irradiation for limited-stage small-cell lung cancer in complete remission.
    Cao KJ; Huang HY; Tu MC; Pan GY
    Chin Med J (Engl); 2005 Aug; 118(15):1258-62. PubMed ID: 16117878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic cranial irradiation in limited-stage small-cell lung cancer: a retrospective analysis.
    Alshehadat S; Sahmoun AE
    Clin Adv Hematol Oncol; 2004 Jun; 2(6):397-400. PubMed ID: 16163213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low doses of prophylactic cranial irradiation effective in limited stage small cell carcinoma of the lung.
    Rubenstein JH; Dosoretz DE; Katin MJ; Blitzer PH; Salenius SA; Floody PA; Harwin WN; Teufel TE; Raymond MG; Reeves JA
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):329-37. PubMed ID: 7673020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.